Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine as Adjunctive Therapy in MDD
NCT01715805Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Nov 2012
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of cariprazine in major depressive disorder (MDD), sponsored by Forest Laboratories. Started Nov 2012; status: completed.
02
Drugs
cariprazine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01715805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01715805.